Back to search

Poland· PL-100439715

Ioflupane (123I) ROTOP

A iodine ioflupane (123i) product containing ioflupanum (123i), registered in Poland by ROTOP Radiopharmacy GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC V09AB03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedIoflupane (123I) ROTOPATCV09AB03REGISTER NO.PL-100439715PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Iodine ioflupane (123i) is registered in 11 of 19 countries.

Countries holding a registration under ATC V09AB03 (iodine ioflupane (123i)), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Iodine ioflupane (123i) · ATC V09AB03

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ioflupanum (123I)
Manufacturer
ROTOP Radiopharmacy GmbH
Country
Poland (PL)
ATC code
V09AB03
ATC class
Iodine ioflupane (123I)
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991468927
  • gtin
    05909991468934

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Iodine ioflupane (123i) in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodine ioflupane (123i) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9f579f6-f18b-4046-8ee3-30dca7dc0cae
GET /v1/drugs/b9f579f6-f18b-4046-8ee3-30dca7dc0cae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "74 MBq/ml",
  "packaging": "05909991468927 ¦ Lz ¦ 142377\n1 fiol. 2,5 ml\n¦ UR/Z/4c/112/24 - 05909991468927 ¦ UR/Z/4c/008/23 - 05909991468927 ¦ UR/Z/4c/217/24 - 05909991468927 ¦ UR/Z/4c/169/23 - 05909991468927 ¦ UR/Z/4c/081/22 - 05909991468927 ¦ UR/Z/4c/010/22 - 05909991468927 ¦ UR/Z/4c/081/23 - 05909991468927 ¦ UR/Z/4c/157/25 - 05909991468927 ¦ UR/Z/4c/309/25 - 05909991468927 ¦ UR/Z/4c/141/26 - 05909991468927\n05909991468934 ¦ Lz ¦ 142378\n1 fiol. 5 ml\n¦ UR/Z/4c/011/22 - 05909991468934 ¦ UR/Z/4c/082/22 - 05909991468934 ¦ UR/Z/4c/170/23 - 05909991468934 ¦ UR/Z/4c/082/23 - 05909991468934 ¦ UR/Z/4c/113/24 - 05909991468934 ¦ UR/Z/4c/009/23 - 05909991468934 ¦ UR/Z/4c/218/24 - 05909991468934 ¦ UR/Z/4c/158/25 - 05909991468934 ¦ UR/Z/4c/310/25 - 05909991468934 ¦ UR/Z/4c/142/26 - 05909991468934",
  "substance": "Ioflupanum (123I) 0,07 - 0,13 MBq/ml",
  "common_name": "Ioflupanum (123I)",
  "pl_product_id": "100439715",
  "pozwolenie_nr": "26710",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about iodine ioflupane (123i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.